首页 | 本学科首页   官方微博 | 高级检索  
     

麦角甾醇与吉非替尼联合用药协同抑制非小细胞肺癌A549和PC-9细胞增殖
引用本文:米完完,黄挺,张梦迪,黄绳武. 麦角甾醇与吉非替尼联合用药协同抑制非小细胞肺癌A549和PC-9细胞增殖[J]. 中国药理学与毒理学杂志, 2020, 0(3): 196-206
作者姓名:米完完  黄挺  张梦迪  黄绳武
作者单位:1.浙江中医药大学药学院;2.杭州红十字会医院普外科
基金项目:国家自然科学基金(81473361);浙江省医药卫生科研项目(2020365132)。
摘    要:目的研究麦角甾醇(ERG)与吉非替尼(GEF)联合用药协同对非小细胞肺癌A549(GEF耐药细胞)和PC-9(GEF敏感细胞)细胞的抑制作用。方法将人肺癌细胞A549和PC-9细胞分别分为对照组、ERG 5~160μmol·L-1单药组、GEF 5~160μmol·L-1(A549)或0.625~20μmol·L-1(PC-9)单药组及不同浓度ERG+GEF联合用药组,MTT法测定细胞增殖;Hoechst 33258观察细胞核形态变化;流式细胞术测定细胞凋亡率及细胞周期;Western印迹法检测蛋白质丝氨酸苏氨酸激酶(Akt),磷酸化AKT(p-Akt),表皮生长因子受体(EGFR),磷酸化EGFR(p-EGFR)蛋白的表达。结果在不同作用时间点,与ERG和GEF单药组相比,相应浓度两药联用组对A549和PC-9细胞的增殖抑制率提高(P<0.01),表现出明显的协同效应(q>1.15);Hoechst 33258凋亡染色结果显示,与单药组相比,联用组A549细胞和PC-9细胞各给药组细胞出现明显核分叶、碎裂、...

关 键 词:麦角甾醇  吉非替尼  抑制  细胞凋亡  细胞周期

Co-administration of ergosterol and gefitinib inhibits proliferation of non-small cell lung cancer A549 and PC-9 cells
MI Wan-wan,HUANG Ting,ZHANG Meng-di,HUANG Sheng-wu. Co-administration of ergosterol and gefitinib inhibits proliferation of non-small cell lung cancer A549 and PC-9 cells[J]. Chinese Journal of Pharmacology and Toxicology, 2020, 0(3): 196-206
Authors:MI Wan-wan  HUANG Ting  ZHANG Meng-di  HUANG Sheng-wu
Affiliation:(College of Pharmaceutical Science,Zhejiang Chinese Medical University,Hangzhou 311402,China;Department of General Surgery,Hangzhou Red Cross Hospital,Hangzhou 310003,China)
Abstract:OBJECTIVE To study the inhibitory effect of ergosterol(ERG)combined with gefitinib(GEF)on non-small cell lung cancer A549(GEF-resistant cells)and PC-9(GEF-sensitive cells)cells.METHODS Human lung cancer cells A549 and PC-9 cells were divided into control group,ERG 5-160μmol·L-1 single drug group,GEF 5-160μmol·L-1 or 0.625-20μmol·L-1 single drug group and different concentrations of ERG+GEF combined drug groups.MTT method was used for in vitro proliferation inhibition test.Hoechst 33258 was used to observe the changes in nuclear morphology.Flow cytometry was used to determine the apoptosis rate and cell cycle,while Western blotting was used to detect the expressions of Akt,p-Akt,epiodermal grouth factor receptor(EGFR)and p-EGFR proteins.RESULTS At different time points,compared with the ERG and GEF single drug groups,the corresponding concentra⁃tion of the two-drug combination groups increased the proliferation inhibitory rate of A549 and PC-9 cells(P<0.01),showing a significant synergistic effect(q>1.15).The results of Hoechst 33258 apoptosis staining showed that A549 cells and PC-9 cells in the combination groups showed typical apoptotic characteristics,such as obvious nuclear lobes,fragmentation,apoptotic bodies,and different nuclear sizes.The apoptosis rate of A549 cells in ERG+GEF(10+10)μmol·L-1 and(40+40)μmol·L-1 groups was higher than that in the corresponding concentration of GEF and ERG single drug groups(P<0.01).And the apoptosis rate of PC-9 cells in ERG+GEF(40+5)μmol·L-1 and(80+10)μmol·L-1 groups was significantly higher(P<0.01).The p-EGFR/EGFR protein expression ratio of A549 cells in the two-drug combination groups(20+20)μmol·L-1 was significantly reduced(P<0.01).The p-Akt/Akt and p-EGFR/EGFR protein expression ratios of PC-9 cells(40+5)μmol·L-1 in the two-drug combination groups were significantly reduced(P<0.05,P<0.01).Cell cycle results showed that for A549 cells,the combination of the two drugs changed the ratio of G0/G1,G2/M,and S phase cells,mainly blocking the cells in G0/G1 phase.For PC-9 cells,the combination of the two drugs did not change the ratio of G0/G1,G2/M,or S phase cells.CONCLUSION The combination of ERG or GEF synergistically inhibits the proliferation of A549 and PC-9 cells and induces apoptosis,its mechanism of action may be related to the inhibition of EGFR signaling pathway related proteins.
Keywords:ergosterol  gefitinib  inhibition  cell apoptosis  cell cycle
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号